Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Synlogic Announces Closing of $21.0 Million Underwritten Public Offering
-
Myeloid Therapeutics to Participate at Upcoming Investor Conferences
-
SAB Biotherapeutics (SABS) Announces Private Placement of up to $130 Million
-
SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes
-
Synlogic (SYBX) Prices 7.39M Share Offering at $2.84/sh
-
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering
-
Atamyo Therapeutics Announces participation in Conferences and Key Scientific Communications on its LGMD programs
-
Coave Therapeutics to Present at Upcoming Conferences
-
ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference
-
ARTHEx Biotech to Present at Chardan's 7th Annual Genetic Medicines Conference
-
Dyne Therapeutics to Present at October Investor Conferences
-
Krystal Biotech to Present at the Chardan 7th Annual Genetic Medicines Conference
-
Ocugen to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference
-
Flamingo Therapeutics Announces Participation at Upcoming Investor and Industry Conferences
-
Senti Bio to Participate in Upcoming Conferences
-
Rocket Pharmaceuticals to Participate in the Chardan 7th Annual Genetic Medicines Conference
-
Insmed To Present at Chardan's 7th Annual Genetic Medicines Conference
-
Silence Therapeutics to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference
-
Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference
-
Locanabio Announces Participation in Chardan’s 7th Annual Genetic Medicines Conference
-
Avidity Biosciences to Participate in Upcoming Investor Conferences
-
Gardiner Healthcare Acquisitions Corp. Announces Intent to Extend
-
Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference
-
Vor Bio to Participate in Upcoming Investor Conferences
-
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
-
Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference
-
Adverum Biotechnologies to Participate in Upcoming Investor Conferences
-
Omega Therapeutics to Participate in Two Upcoming Investor Conferences
-
Synlogic to Participate in Chardan’s Genetic Medicines Conference
-
Sensorion Announces Webconference on September 25, 2023, and its Participation in Upcoming Investor Conferences in October 2023
-
Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing
-
Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing
-
Solid Biosciences to Participate at Upcoming Investor Conferences
-
Prime Medicine to Present at Upcoming Investor Conferences
-
4DMT to Participate in Upcoming Investor Conferences
-
Genenta to Present at Upcoming Scientific and Investor Conferences
-
Myeloid Therapeutics to Participate at Upcoming Investor Conferences
-
Form SC 13D Gardiner Healthcare Acqu Filed by: Chardan Gardiner LLC
-
Abata Therapeutics to Present and Participate in Upcoming Investor and Industry Events
-
CORRECTING and REPLACING Gardiner Healthcare Acquisitions Corp. Receives Notice Regarding Late Form 10-Q Filing From The Nasdaq Stock Market LLC
-
Gardiner Healthcare Acquisitions Corp. Receives Notice Regarding Late Form 10-Q Filing From The Nasdaq Stock Market LLC
-
Gardiner Healthcare Acquisitions Corp. Announces Intent to Extend
-
Arcturus Therapeutics to Attend Upcoming Investor Conferences
-
Lendway, Inc. Announces Second Quarter 2023 Financial Results
-
Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023
-
Allurion Debuts as a Publicly Traded Company on the NYSE
-
Inpixon (INPX) Enters into Definitive Merger Agreement with XTI Aircraft Company
-
Better Therapeutics (BTTX) Announces $6.7M Financing at $0.77/sh
-
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
-
Inpixon Enters into Definitive Merger Agreement with XTI Aircraft Company, Developer of a Vertical Lift Crossover Airplane (VLCA)

